Rationalization of the Activity of Medical Ozone on Intervertebral Disc A Histological and Biochemical Study

Abstract

Italian

Ozonetherapy is used for the treatment of immunodeficiency syndromes as well as for the treatment of cardiovascular disease. It is also used for the treatment of low back-pain with promising results although it is not yet well established.

The aim of the current study is the presentation of the effects of ozonetherapy injected intradiscally or paravertebrally.

We present the histological, immunological and biochemical changes in vertebral discs.

Our material consist of human specimens as well as New Zealand rabbits.

Keywords

medical ozone herniated disc cytokines

Get full access to this article

View all access options for this article.

References

Beautler

Krochin

: Control of cachectin (tumor necrosis factor) synthesis. Mechanisms of endotoxin resistance. Science 232: 977–980, 1986.

Bocci

: Ozonization of blood for the therapy of viral diseases and immunodeficiencies. A hypothesis. Med Hypotheses 39: 30–34, 1992.

Bocci

: Autohaemotherapy after treatment of blood with ozone. A reappraisal. J Int Med Res 22: 131–144, 1994.

Bocci

Paulesu

: Studies on the biological effects of ozone. 1) Induction of interferon gamma on human leucocytes. Haematologica 75: 510–515, 1990.

Bocci

Luzzi

: Studies on the biological effects of ozone. 5) Evaluation of immunological parameters and tolerability in normal volunteers receiving ambulatory Autohaemotherapy. Biotherapy Biophys Acta 1271: 67–64, 1995.

Bocci

Lucci

: Studies on the biological effects of ozone. 5) Evaluation of immunological parameters and tolerability in normal volunteers receiving ambulatory autohaemotherapy. Biotherapy 7: 83–90, 1994.

Bonetti

Cotticelli

: Oxygen-ozone therapy vs epidural steroids injections. Rivista di Neuroradiologia 13: 203–206, 2000.

Coppola

: Oxygen-ozone therapy and peripheral chronic arterial occlusive disease. Thombosi & Aterosclerosi 3(2): 83–89, 1992.

Dayer

Breard

: Participation of monocytemacrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells. J Clin Invest 64: 1386–1392, 1979.

10.

Fahmy

: Ozone therapy in rheumatic disease. Kongrelberientht 10 A. Ozon therapie bei Erkrankungen der rheumatischen Formenkreises. Ozo Nanhrichten 4: 79, 1985.

11.

Franzini

: Subctaneous oxygen-ozone therapy in inductive hypodermatitis and in localised lipodystrophies a Clinical Study of Efficacy and Tolerability. Acta Toxicologica et Therapeutica, 1994.

12.

Goldring

: Cytokines and Skeletal Physiology. Clin Orthop and rel resh 324: 13–23, 1996.

13.

Guerne

Carson

Lotz

: IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol 144: 499–505, 1990.

14.

Halliwell

: Free radicals and antioxidants a personal view. Nutr Rev 52: 253–265, 1994.

15.

Iliakis

: Ozone treatment in low back pain. Orthopaedics 1: 29–33, 1995.

16.

Iliakis

: Utilizzo dell'ossigeno-ozonoterapia nella pratica ortopedica. Acta Toxicol Ther XVII(2–3): 249–253, 1996.

17.

Kawakami

Ikeda

: Stydies of conditions and agents that stimulate and inhibit production of cachectin by macrophages. In: Patton

Mitchel

Turner

, (eds): IUPHAR 9th International Congress of Pharmacology. Macmillan Press, London 1984: 377–384.

18.

Luedke

Cerami

: Interferon-γ overcomes glucocorticoid suppression of cachectin tumor necrosis factor biosynthesis by murine macrophages. J Clin Invest 86: 1234–1240, 1990.

19.

Mattashi

: Ozonetherapia. Organizzazione Editoriale Medico Farmaceutica, Milano 1985: 1–179.

20.

Miyasaka

Sato

: Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Arthritis Rheum 31: 480–486, 1988.

21.

Paulescu

Luzzi

Bocci

: Studies on the biological effects of ozone. 2) Induction of tumor necrosis factor (TNF-α) on human leukocytes. Lymphokine Cytokine Res 10: 409–412, 1991.

22.

Paulescu

: Studies on the biological effects of ozone. 2) Induction of tumor necrosis factor (TNF-α) on human leukocytes. Lymphocaine e Cytokaine Research 10(5): 409–412, 1991.

23.

Pelletier

: Pathological partwass of osteoarthritis. Int Congr and Symp. Series No 208. Royal Society of Medicine Press 1994.

24.

Resnick

Niwayama

: Diagnosis of bone and join disorders. W.B. Saunderes, Philadelphia PA 1988.

25.

Sanseverino

E Riva

: Knee-joint disorders treated by oxygen-ozone therapy. Eur Medicophysica 25: 163–170, 1989.

26.

Sanseverino

E Riva

: Intensive medical physical treatment of osteoporosis with the aid of oxygen-ozone therapy. Europa Medicophysica 25(3): 163–170, 1989.

27.

Shinmei

Masuda

Kikutsi

: The role of cytokines in chondrocyte mediated cartilage degeneration. J Reumatol 18 (Suppl 16): 32–34, 1989.

28.

Shinmei

Masuda

: Production of cytokines by chondrocytes and its role in proteoglycan degradation. J Reumatol 18 (27 Suppl): 89–91, 1991.

29.

Snyder

Umanne

: Corticosteroids inhibit murine macrophase la expression and interleukin 1 production. J Immunol 129: 1803–1805, 1982.

30.

Takahashi

: Inflammatory cytokines in the herniated disc of the lumbar spine. Spine 21(2): 218–224, 1996.

31.

Utito

Prokop

: Synthesis and secretion of underhydroxylated procollagen at various temperatures by cells subjects to temporally anoxia. Biochem Biophys Commun 60: 414, 1974.

32.

Vacca

Martinotti

: Transcriptional regulation of the interleukin 2 gene by glcocorticoid hormones. J Biol Chem, 8075–8080, 1990.

33.

Verga

: Nuovo approccio terapeutico alle ernie e protrusioni discali. Rivista di Neuroradiologia 2(suppl), 1989.

34.

Verrazzo

Coppola

: Hyperbaric oxygen, oxygen-ozone therapy and rheologic parameters of blood in patients with peripheral occlusive arterial disease. Undersea Hyperbar Med 2: 17–22, 1995.

35.

Viebahn

: The use of ozone in medicine. 2nd ed. Karl F. Hang Publishers, Heidelderg 1994: 1–178.